Blog Post

MEC in Q4 2025: A Turning Point in Life Sciences: JPM 2026 Ushers in a Return to Biotech and the AI-Era

MEC 2025 Year in Review

MEC Newsletter: MEC in Q3 2025 – The Road Ahead

MEC Newsletter: Q2 2025 – The Future of Precision Regenerative Medicine: MEC’s Investments in Induced Pluripotent Stem Cell Therapies

MEC Newsletter: Q1 2025 – Biotech’s Next Chapter: What We Learned at Stanford—and Why Unity Is the New Imperative

MEC Newsletter: 2024 Year-End Retrospective – A Year of Materiality, A Year of Progress

Q3 2024 MEC Newsletter

MEC in Q2 2024

MEC in Q1 2024

2023 – A Year in Retrospect